173 related articles for article (PubMed ID: 28454190)
1. Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In Vitro and In Vivo Models.
Piwowarski JP; Bobrowska-Korczak B; Stanisławska I; Bielecki W; Wrzesien R; Granica S; Krupa K; Kiss AK
Planta Med; 2017 Oct; 83(14-15):1159-1168. PubMed ID: 28454190
[No Abstract] [Full Text] [Related]
2. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
3. Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.
Kiss A; Kowalski J; Melzig MF
Phytomedicine; 2006 Mar; 13(4):284-9. PubMed ID: 16492533
[TBL] [Abstract][Full Text] [Related]
4. Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.
Stolarczyk M; Piwowarski JP; Granica S; Stefańska J; Naruszewicz M; Kiss AK
Phytother Res; 2013 Dec; 27(12):1842-8. PubMed ID: 23436427
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the effect of Epilobium extracts on human cell proliferation.
Vitalone A; McColl J; Thome D; Costa LG; Tita B
Pharmacology; 2003 Oct; 69(2):79-87. PubMed ID: 12928581
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed).
Schepetkin IA; Ramstead AG; Kirpotina LN; Voyich JM; Jutila MA; Quinn MT
Phytother Res; 2016 Aug; 30(8):1287-97. PubMed ID: 27215200
[TBL] [Abstract][Full Text] [Related]
7. Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial.
Esposito C; Santarcangelo C; Masselli R; Buonomo G; Nicotra G; Insolia V; D'Avino M; Caruso G; Buonomo AR; Sacchi R; Sommella E; Campiglia P; Tenore GC; Daglia M
Biomed Pharmacother; 2021 Jun; 138():111414. PubMed ID: 33765581
[TBL] [Abstract][Full Text] [Related]
8. Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review.
Granica S; Piwowarski JP; Czerwińska ME; Kiss AK
J Ethnopharmacol; 2014 Oct; 156():316-46. PubMed ID: 25196824
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium.
Schepetkin IA; Kirpotina LN; Jakiw L; Khlebnikov AI; Blaskovich CL; Jutila MA; Quinn MT
J Immunol; 2009 Nov; 183(10):6754-66. PubMed ID: 19846877
[TBL] [Abstract][Full Text] [Related]
10. Effect of Epilobium angustifolium L. extracts and polyphenols on cell proliferation and neutral endopeptidase activity in selected cell lines.
Kiss A; Kowalski J; Melzig MF
Pharmazie; 2006 Jan; 61(1):66-9. PubMed ID: 16454210
[TBL] [Abstract][Full Text] [Related]
11. Extracts from Epilobium sp. herbs induce apoptosis in human hormone-dependent prostate cancer cells by activating the mitochondrial pathway.
Stolarczyk M; Naruszewicz M; Kiss AK
J Pharm Pharmacol; 2013 Jul; 65(7):1044-54. PubMed ID: 23738732
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract.
Dacrema M; Sommella E; Santarcangelo C; Bruno B; Marano MG; Insolia V; Saviano A; Campiglia P; Stornaiuolo M; Daglia M
Biomed Pharmacother; 2020 Nov; 131():110670. PubMed ID: 32896677
[TBL] [Abstract][Full Text] [Related]
13. Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp.
Kiss AK; Bazylko A; Filipek A; Granica S; Jaszewska E; Kiarszys U; Kośmider A; Piwowarski J
Phytomedicine; 2011 May; 18(7):557-60. PubMed ID: 21112753
[TBL] [Abstract][Full Text] [Related]
14. Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFNγ production by lymphocytes.
Ramstead AG; Schepetkin IA; Quinn MT; Jutila MA
PLoS One; 2012; 7(11):e50546. PubMed ID: 23226309
[TBL] [Abstract][Full Text] [Related]
15. Inter-population and inter-organ distribution of the main polyphenolic compounds of Epilobium angustifolium.
Baert N; Kim J; Karonen M; Salminen JP
Phytochemistry; 2017 Feb; 134():54-63. PubMed ID: 27866749
[TBL] [Abstract][Full Text] [Related]
16. Polyphenol composition and antioxidant capacity of Epilobium species.
Hevesi Tóth B; Blazics B; Kéry A
J Pharm Biomed Anal; 2009 Jan; 49(1):26-31. PubMed ID: 19013046
[TBL] [Abstract][Full Text] [Related]
17. In vivo bioactivity assessment on Epilobium species: A particular focus on Epilobium angustifolium and its components on enzymes connected with the healing process.
Karakaya S; Süntar I; Yakinci OF; Sytar O; Ceribasi S; Dursunoglu B; Ozbek H; Guvenalp Z
J Ethnopharmacol; 2020 Nov; 262():113207. PubMed ID: 32730870
[TBL] [Abstract][Full Text] [Related]
18. Aging influences the response of T cells to stimulation by the ellagitannin, oenothein B.
Ramstead AG; Schepetkin IA; Todd K; Loeffelholz J; Berardinelli JG; Quinn MT; Jutila MA
Int Immunopharmacol; 2015 Jun; 26(2):367-77. PubMed ID: 25887271
[TBL] [Abstract][Full Text] [Related]
19. High-performance thin-layer chromatography method for quantitative determination of oenothein B and quercetin glucuronide in aqueous extract of Epilobii angustifolii herba.
Bazylko A; Kiss AK; Kowalski J
J Chromatogr A; 2007 Nov; 1173(1-2):146-50. PubMed ID: 17980376
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5 alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species.
Ducrey B; Marston A; Göhring S; Hartmann RW; Hostettmann K
Planta Med; 1997 Apr; 63(2):111-4. PubMed ID: 9140222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
